Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
52-week randomized trial of lifestyle change, mushroom supplementation, and bupropion in overweight adults
2026-527136-13-00Phase 3Authorised
- Sponsor
- Uppsala University
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of bupropion in Overweight and obesity (2 arms), sponsored by Uppsala University. Primary endpoint: Percent change in body weight from baseline to 6 months. Planned start Aug 2026; status: authorised.
02
Drugs
bupropion
03
Conditions
Overweightobesity
Beyond the preview
Go deeper on 2026-527136-13-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-527136-13-00.